# JiMED

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jimed

- Industry: Medical Devices & Equipment
- Headquarters: Suita, Japan
- Website: www.jimed.jp
- Total disclosed funding: $4.8M
- Latest round: Series A (Feb 13, 2025)
- Investors on record: 5

## About

Based in Osaka, Japan, and founded in 2020, JiMED Inc., d.b.a JiMED engages in the development, manufacturing, and commercialization of wireless implantable brain computer/machine interface (BCI/BMI) devices based on research conducted at Osaka University, with the goal of facilitating clinical applications of implantable BMI systems. In June 2026, JiMED raised JPY 330 million in?venture funding from Keio Innovation Initiative.

JiMED provides BMI (Brain-machine interface) that targets communication with ALS patients and improving their quality of life. Using AI and implanted devices, the system reads brain activity and translates that to voice and gestures, and enables the manipulation of robots. 

The company plans to use the June 2026 funding to accelerate the preparations for clinical trials, enhance collaborations, and facilitate the growth and commercialization of future products.

## Funding rounds

- Series A, Feb 13, 2025, $2.3M — Keio Innovation Initiative, Kyoto University Innovation Capital, GREEN CORE
- Series A, Feb 28, 2023, $1.1M — Osaka University Venture Capital
- Series A, Mar 31, 2021, $1.4M — Mizuho Capital, Osaka University Venture Capital

## Investors

- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A
- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Series A
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A
- GREEN CORE — Series A